Linh Le

Linh Le has been appointed as chief operating officer of Ambry Genetics, which became part of Konica Minolta in October 2017. Most recently, he oversaw financial operations at Medtronic's Diabetes Intensive Insulin business unit. Prior to that, he held leadership roles at the Walt Disney Company, PricewaterhouseCoopers, Twentieth Century Fox, and KPMG.